Dr. Raza Khan, MD
Claim this profileAultman Health Foundation
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
35 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR negative
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Raza Khan, MD is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Observation
for Non-Small Cell Lung Cancer
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
Recruiting1 award N/A10 criteria
More about Raza Khan, MD
Clinical Trial Related11 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Raza Khan, MD has experience with
- Carboplatin
- Pembrolizumab
- Paclitaxel
- Pemetrexed
- Nab-paclitaxel
- Atezolizumab
Breakdown of trials Raza Khan, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Colon Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raza Khan, MD specialize in?
Raza Khan, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Raza Khan, MD currently recruiting for clinical trials?
Yes, Raza Khan, MD is currently recruiting for 9 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Raza Khan, MD has studied deeply?
Yes, Raza Khan, MD has studied treatments such as Carboplatin, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Raza Khan, MD?
Apply for one of the trials that Raza Khan, MD is conducting.
What is the office address of Raza Khan, MD?
The office of Raza Khan, MD is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.